Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality

BACKGROUND: The introduction of BCR-ABL tyrosine kinase inhibitors (TKIs) to chronic myeloid leukemia (CML) therapy has revolutionized the treatment of this disease. Although regular TKI intake is a prerequisite for successful therapy, it has been shown that a significant proportion of patients are...

Descripción completa

Detalles Bibliográficos
Autores principales: Rychter, Anna, Miniszewska, Joanna, Góra-Tybor, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854114/
https://www.ncbi.nlm.nih.gov/pubmed/36658586
http://dx.doi.org/10.1186/s13030-023-00261-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854114/
https://www.ncbi.nlm.nih.gov/pubmed/36658586
http://dx.doi.org/10.1186/s13030-023-00261-w

Ejemplares similares